Detalhe da pesquisa
1.
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
J Immunol
; 189(3): 1418-30, 2012 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22772445
2.
Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.
PLoS Genet
; 6(11): e1001192, 2010 Nov 04.
Artigo
Inglês
| MEDLINE | ID: mdl-21079681
3.
Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.
J Immunol
; 185(7): 4233-7, 2010 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20802150
4.
Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells.
J Immunol
; 185(7): 4238-51, 2010 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20805421
5.
Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.
Proc Natl Acad Sci U S A
; 106(44): 18692-7, 2009 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-19837691
6.
Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.
J Immunol
; 182(6): 3628-37, 2009 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19265141
7.
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors.
J Immunol
; 182(6): 3618-27, 2009 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19265140
8.
Primate-specific regulation of natural killer cells.
J Med Primatol
; 39(4): 194-212, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20618586
9.
Targeting CD39 in cancer.
Nat Rev Immunol
; 20(12): 739-755, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32728220
10.
Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
Cancer Immunol Res
; 8(3): 356-367, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31992567
11.
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.
Cancer Discov
; 9(12): 1754-1773, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31699796
12.
Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade.
Clin Cancer Res
; 23(20): 6190-6202, 2017 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28706012
13.
Peptide register shifting within the MHC groove: theory becomes reality.
Mol Immunol
; 40(14-15): 1033-9, 2004 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15036907
14.
The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay.
J Immunol Methods
; 425: 79-87, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26096968
15.
T cell receptor Beta chain gene usage in endemic pemphigus foliaceus (fogo selvagem).
J Invest Dermatol
; 119(2): 377-83, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12190860
16.
Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.
Front Immunol
; 3: 336, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23189078
17.
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.
J Exp Med
; 206(11): 2557-72, 2009 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-19858347
18.
Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.
Genome Res
; 19(5): 757-69, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19411600
19.
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
J Immunol
; 180(6): 3969-79, 2008 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18322206